Dynamics in Post-pandemic Global Hepatitis B Vaccines Industry: Supply and Demand, Markets and Prices 2021-2027
Table of Contents
1 Product Introduction and Overview
- 1.1 Product Definition
- 1.2 Product Specification
- 1.3 Global Market Overview
- 1.3.1 Global Hepatitis B Vaccines Market Status and Forecast (2016-2027)
- 1.3.2 Global Hepatitis B Vaccines Sales Value CAGR by Region
- 1.4 Market Drivers, Inhibitors
- 1.4.1 Market Drivers
- 1.4.2 Market Inhibitors
- 1.4.3 COVID-19 Impact Analysis
2 Global Hepatitis B Vaccines Supply by Company
- 2.1 Global Hepatitis B Vaccines Sales Volume by Company
- 2.2 Global Hepatitis B Vaccines Sales Value by Company
- 2.3 Global Hepatitis B Vaccines Price by Company
- 2.4 Hepatitis B Vaccines Production Location and Sales Area of Main Manufacturers
- 2.5 Trend of Concentration Rate
3 Global and Regional Hepatitis B Vaccines Market Status by Category
- 3.1 Hepatitis B Vaccines Category Introduction
- 3.1.1 Yeast Derived
- 3.1.2 CHO Derived
- 3.2 Global Hepatitis B Vaccines Market by Category
- 3.2.1 Global Hepatitis B Vaccines Sales Volume by Category (2016-2021)
- 3.2.2 Global Hepatitis B Vaccines Sales Value by Category (2016-2021)
- 3.2.3 Global Hepatitis B Vaccines Price by Category (2016-2021)
- 3.3 North America: by Category
- 3.4 Europe: by Category
- 3.5 Asia Pacific: by Category
- 3.6 Central & South America: by Category
- 3.7 Middle East & Africa: by Category
4 Global and Regional Hepatitis B Vaccines Market Status by End User/Segment
- 4.1 Hepatitis B Vaccines Segment by End User/Segment
- 4.1.1 Kids
- 4.1.2 Adult
- 4.2 Global Hepatitis B Vaccines Market by End User/Segment
- 4.2.1 Global Hepatitis B Vaccines Sales Volume by End User/Segment (2016-2021)
- 4.2.2 Global Hepatitis B Vaccines Sales Value by End User/Segment (2016-2021)
- 4.2.3 Global Hepatitis B Vaccines Price by End User/Segment (2016-2021)
- 4.3 North America: by End User/Segment
- 4.4 Europe: by End User/Segment
- 4.5 Asia Pacific: by End User/Segment
- 4.6 Central & South America: by End User/Segment
- 4.7 Middle East & Africa: by End User/Segment
5 Global Hepatitis B Vaccines Market Status by Region
- 5.1 Global Hepatitis B Vaccines Market by Region
- 5.1.1 Global Hepatitis B Vaccines Sales Volume by Region
- 5.1.2 Global Hepatitis B Vaccines Sales Value by Region
- 5.2 North America Hepatitis B Vaccines Market Status
- 5.3 Europe Hepatitis B Vaccines Market Status
- 5.4 Asia Pacific Hepatitis B Vaccines Market Status
- 5.5 Central & South America Hepatitis B Vaccines Market Status
- 5.6 Middle East & Africa Hepatitis B Vaccines Market Status
6 North America Hepatitis B Vaccines Market Status
- 6.1 North America Hepatitis B Vaccines Market by Country
- 6.1.1 North America Hepatitis B Vaccines Sales Volume by Country (2016-2021)
- 6.1.2 North America Hepatitis B Vaccines Sales Value by Country (2016-2021)
- 6.2 United States
- 6.3 Canada
- 6.4 Mexico
7 Europe Hepatitis B Vaccines Market Status
- 7.1 Europe Hepatitis B Vaccines Market by Country
- 7.1.1 Europe Hepatitis B Vaccines Sales Volume by Country (2016-2021)
- 7.1.2 Europe Hepatitis B Vaccines Sales Value by Country (2016-2021)
- 7.2 Germany
- 7.3 France
- 7.4 UK
- 7.5 Italy
- 7.6 Russia
- 7.7 Spain
8 Asia Pacific Hepatitis B Vaccines Market Status
- 8.1 Asia Pacific Hepatitis B Vaccines Market by Country
- 8.1.1 Asia Pacific Hepatitis B Vaccines Sales Volume by Country (2016-2021)
- 8.1.2 Asia Pacific Hepatitis B Vaccines Sales Value by Country (2016-2021)
- 8.2 China
- 8.3 Japan
- 8.4 Korea
- 8.5 Southeast Asia
- 8.6 India
- 8.7 Australasia
9 Central & South America Hepatitis B Vaccines Market Status
- 9.1 Central & South America Hepatitis B Vaccines Market by Country
- 9.1.1 Central & South America Hepatitis B Vaccines Sales Volume by Country (2016-2021)
- 9.1.2 Central & South America Hepatitis B Vaccines Sales Value by Country (2016-2021)
- 9.2 Brazil
- 9.3 Argentina
- 9.4 Colombia
10 Middle East & Africa Hepatitis B Vaccines Market Status
- 10.1 Middle East & Africa Hepatitis B Vaccines Market by Country
- 10.1.1 Middle East & Africa Hepatitis B Vaccines Sales Volume by Country (2016-2021)
- 10.1.2 Middle East & Africa Hepatitis B Vaccines Sales Value by Country (2016-2021)
- 10.2 Iran
- 10.3 Israel
- 10.4 Turkey
- 10.5 South Africa
- 10.8 Saudi Arabia
11 Sales Channel, Distributors and Buyers
- 11.1 Sales Channel
- 11.1.1 Direct Sales
- 11.1.2 Channel Sales
- 11.2 Hepatitis B Vaccines Distributors
- 11.3 Hepatitis B Vaccines Buyers
12 Global Hepatitis B Vaccines Market Forecast by Category and by End User/Segment
- 12.1 Global Hepatitis B Vaccines Sales Volume and Sales Value Forecast (2022-2027)
- 12.2 Global Hepatitis B Vaccines Forecast by Category
- 12.2.1 Global Hepatitis B Vaccines Sales Volume Forecast by Category
- 12.2.2 Global Hepatitis B Vaccines Sales Value Forecast by Category
- 12.2.3 Global Hepatitis B Vaccines Price Forecast by Category
- 12.3 Global Hepatitis B Vaccines Forecast by End User/Segment
- 12.3.1 Global Hepatitis B Vaccines Sales Volume Forecast by End User/Segment
- 12.3.2 Global Hepatitis B Vaccines Sales Value Forecast by End User/Segment
- 12.3.3 Global Hepatitis B Vaccines Price Forecast by End User/Segment
13 Global Hepatitis B Vaccines Market Forecast by Region/Country
- 13.1 Global Hepatitis B Vaccines Market Forecast by Region (2022-2027)
- 13.1.1 Global Hepatitis B Vaccines Sales Volume Forecast by Region (2022-2027)
- 13.1.2 Global Hepatitis B Vaccines Sales Value Forecast by Region (2022-2027)
- 13.2 North America Market Forecast
- 13.3 Europe Market Forecast
- 13.4 Asia Pacific Market Forecast
- 13.5 Central & South America Market Forecast
- 13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
- 14.1 GSK
- 14.1.1 Company Information
- 14.1.2 Hepatitis B Vaccines Product Introduction
- 14.1.3 GSK Hepatitis B Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.1.4 Contact Information
- 14.2 NCPC
- 14.2.1 Company Information
- 14.2.2 Hepatitis B Vaccines Product Introduction
- 14.2.3 NCPC Hepatitis B Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.2.4 Contact Information
- 14.3 KM Biologics
- 14.3.1 Company Information
- 14.3.2 Hepatitis B Vaccines Product Introduction
- 14.3.3 KM Biologics Hepatitis B Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.3.4 Contact Information
- 14.4 LG Life Sciences
- 14.4.1 Company Information
- 14.4.2 Hepatitis B Vaccines Product Introduction
- 14.4.3 LG Life Sciences Hepatitis B Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.4.4 Contact Information
- 14.5 Merck
- 14.5.1 Company Information
- 14.5.2 Hepatitis B Vaccines Product Introduction
- 14.5.3 Merck Hepatitis B Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.5.4 Contact Information
- 14.6 Dynavax
- 14.6.1 Company Information
- 14.6.2 Hepatitis B Vaccines Product Introduction
- 14.6.3 Dynavax Hepatitis B Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.6.4 Contact Information
- 14.7 Hissen
- 14.7.1 Company Information
- 14.7.2 Hepatitis B Vaccines Product Introduction
- 14.7.3 Hissen Hepatitis B Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.7.4 Contact Information
- 14.8 Bio Kangtai
- 14.8.1 Company Information
- 14.8.2 Hepatitis B Vaccines Product Introduction
- 14.8.3 Bio Kangtai Hepatitis B Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.8.4 Contact Information
- 14.9 Serum Institute
- 14.9.1 Company Information
- 14.9.2 Hepatitis B Vaccines Product Introduction
- 14.9.3 Serum Institute Hepatitis B Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.9.4 Contact Information
15 Conclusion
Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Hepatitis B Vaccines market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Hepatitis B Vaccines market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.
Segmented by Category
Yeast Derived
CHO Derived
Segmented by End User/Segment
Kids
Adult
Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia
Key manufacturers included in this survey
GSK
NCPC
KM Biologics
LG Life Sciences
Merck
Dynavax
Hissen
Bio Kangtai
Serum Institute